Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial

Journal of Cardiac Failure

Volumn 18, Issue 6, 2012, Pages 446-458

  Costanzo, Maria Rosa ^a   Ivanhoe, Russell J ^b   Kao, Andrew ^c   Anand, Inder S ^d   Bank, Alan ^e   Boehmer, John ^f   Demarco, Teresa ^g   Hergert, Cheryl M ^b   Holcomb, Richard G ^b   Maybaum, Simon ^h   Sun, Benjamin ⁱ   Vassiliades, Thomas A ^j   Rayburn, Barry K ^k   Abraham, William T ^l  

^a Edward Heart Hospital   (United States)

^b Paracor Medical Inc ^*  (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d VA MEDICAL CENTER   (United States)

^e St Paul Heart Clinic   (United States)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MONTEFIORE MEDICAL CENTER   (United States)

ⁱ MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^j Medtronic   (United States)

^k Cardiovascular Associates PC   (United States)

^l THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

more..

Author keywords

Elastic Restraint; functional capacity; heart failure; quality of life

Indexed keywords

6 MINUTE WALK DISTANCE; ACUTE CORONARY SYNDROME; ADULT; ALCOHOL WITHDRAWAL; ANEMIA; ANGINA PECTORIS; ARTICLE; BACTEREMIA; BLEEDING; CARDIAC PATIENT; CARDIAC RESTRAINT DEVICE; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEHYDRATION; DEVICE SAFETY; DEVICES; DISEASE EXACERBATION; EMBOLISM; EVALUATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HUMAN; HYPOTENSION; ILEUS; IMPLANTATION; KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE; KIDNEY FAILURE; LARYNX GRANULOMA; LEFT VENTRICULAR ENDDIASTOLIC DIAMETER; LEFT VENTRICULAR ENDSYSTOLIC DIAMETER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HEART FAILURE SCORE; MULTICENTER STUDY; NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEPSIS; SLEEP APNEA SYNDROME; STROKE; SYNCOPE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84861621367     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.04.004     Document Type: Article

References (46)

1. M. Jessup, W.T. Abraham, and D.E. Casey 2009 Focused update incorporated into the tACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults Circulation 119 2009 e391 e479
2. C.M. Yu, J. Wing-Hong Fung, Q. Zhang, and J.E. Sanderson Understanding nonresponders of cardiac resynchronization therapy- current and future perspectives J Cardiovasc Electrophysiol 16 2005 1117 1124
3. J.N. Cohn Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition Circulation 91 1995 2504 2507
4. P.S. Douglas, R. Morrow, A. Ioli, and N. Reicheck Left ventricular shape, afterload, and survival in idiopathic dilated cardiomyopathy J Am Coll Cardiol 13 1989 311 315
5. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, and D. Levy Left ventricular dilation and the risk of congestive heart failure in people without myocardial infarction N Engl J Med 336 1997 1350 1355
6. D.G. Kramer, T.A. Trikalinos, D.M. Kent, G.V. Antronopoulos, M.A. Konstam, and J.E. Udelson Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach J Am Coll Cardiol 56 2010 392 406
7. M. Merlo, S.A. Pyxaras, B. Pinamonti, G. Barbati, A. Di Lenarda, and G. Sinagra Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment J Am Coll Cardiol 57 2011 1468 1476
8. P.A. Chaudry, T. Mishima, V.G. Sharov, J. Hawkins, C. Alferness, G. Paone, and H.N. Sabbah Passive epicardial containment prevents ventricular remodeling in heart failure Ann Thorac Surg 70 2000 1275 1280
9. H.A. Sabbah, V.G. Sharov, R.C. Gupta, S. Mishra, S. Rastogi, and A.I. Undrovinas Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment Circ Res 93 2003 1095 1101
10. W.F. Saavedra, R.S. Tunin, N. Paolocci, T. Mishima, G. Suzuki, and C.W. Emala Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure J Am. Coll. Cardiol 39 2002 2069 2076
11. H.N. Sabbah Effect of cardiac support device on reverse remodeling: molecular, biochemical, and structural mechanisms J Cardiac Fail 10 6 Suppl 2004 S207 S214
12. D.A. Kass, F. Saavedra, and H.N. Sabbah Reverse remodeling and enhanced inotropic reserve from the cardiac support device in heart failure J Cardiac Fail 10 6 Suppl 2004 S215 S219
13. V.G. Sharov, A.V. Todor, and H.N. Sabbah Left ventricular histomorphometric findings in dogs with heart failure treated with the Acorn Cardiac Support Device Heart Fail Rev 10 2005 141 147
14. H.N. Sabbah Global left ventricular remodeling with the Acorn Cardiac Support Device: hemodynamic, and angiographic findings in dogs with heart failure Heart Fail Rev 10 2005 109 115
15. S. Rastogi, R. Gupta, S. Mishra, H. Morita, E.J. Tanhehoo, and H.N. Sabbah Long-Term therapy with the Acorn Cardiac Support Device normalizes gene expression of growth factors and gelatinases in dogs with heart failure J Heart Lung Transplant 24 2005 1619 1625
16. D.L. Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, and S.H. Kubo Clinical rvaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy Ann Thorac Surg 84 2007 1226 1235
17. R.C. Starling, M. Jessup, J.K. Oh, H.N. Sabbah, M.A. Acker, D.L. Mann, and S.H. Kubo Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn Clinical Trial Ann Thorac Surg 84 2007 1236 1242
18. F. Bredin, and A. Franco-Cereceda Midterm results of passive containment surgery using the Acorn CorCap™ Cardiac Support Device in dilated cardiomyopathy J Card Surg 25 2010 107 112
19. C.T. Klodell, D.C. McGiffin, B.K. Rayburn, B. Sun, W.T. Abraham, and J.V. Conte Initial United States experience with the Paracor HeartNet Myocardial Constraint Device for heart failure J Thorac Cardiovasc Surg 133 2007 204 209
20. C.T. Klodell, J.M. Aranda, D.C. McGiffin, B.C. Rayburn, B. Sun, and W.T. Abraham Worldwide Surgical Experience with the Paracor HeartNet Cardiac restraint Device J Thorac Cardiovasc Surg 135 2008 188 195
21. M.R. Costanzo, R. Virmani, I. Anand, J. Aranda, and R.J. Ivanhoe The long term healing response following implant of the HeartNet Elastic Support System J Cardiac Fail 14 Suppl 2008 S55 S56
22. Abraham WT, Anand I, Aranda JM, Jr., Boehmer J, Costanzo MR, De Marco T, et al. Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: rationale and design. Am Heart J. In press.
23. U. Corra, A. Mezzani, E. Bosimini, and P. Giannuzzi Prognostic value of time-related changes of cardiopulmonary exercise testing indices in stable chronic heart failure: a pragmatic and operative scheme Eur J Cardiovasc Prev Rehabil 13 2006 186 192
24. J. Myers, L. Gullestad, R. Vagelos, D. Bellin, H. Ross, and M.B. Fowler Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited Am Heart J 139 2000 78 84
25. T. Kavanagh, D.J. Mertens, L.F. Hamm, J. Beyene, J. Kennedy, P. Corey, and R.J. Shephard Prediction of long-term prognosis in 12169 men referred for cardiac rehabilitation Circulation 106 2002 666 671
26. T. Kavanagh, D.J. Mertens, L.F. Hamm, J. Beyene, J. Kennedy, P. Corey, and R.J. Shephard Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation J Am Coll Cardiol 42 2003 2139 2143
27. W.C. Blackwelder Proving the null hypothesis in clinical trials Controlled Clinical Trials 3 1982 345 353
28. C.P. Farrington, and G. Manning Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk Stat Med 9 1990 1447 1454
29. D. Mancini, and T.H. LeJemtel Is ventilatory classification preferable to peak oxygen consumption for risk stratification in heart Failure? Circulation 115 2007 2376 2378
30. S.J. Keteyian, C.A. Brawner, J.K. Ehrman, R. Ivanhoe, J.P. Boehmer, W.T. Abraham for the PEERLESS Investigators Reproducibility of peak oxygen uptake and other cardiopulmonary exercise parameters. implications for clinical trials and clinical practice Chest 138 2010 950 955
31. R. Arena, J. Myers, J. Abella, M.A. Peberdy, D. Bensimhon, P. Chase, and M. Guazzi Development of a ventilatory classification system in patients with heart failure Circulation 115 2007 2410 2417
32. A. Cohen-Solal, J.F. Aupetit, P. Gueret, H. Kolski, F. Zannad on Behalf of the VO2 French Study Group Can anerobic threshold be used as an end-point for therapeutic trials in heart Failure? Lessons from a multicenter placebo-controlled trial Eur Heart J 15 1994 236 241
33. V. Bittner, D.H. Weiner, S. Yusuf, W.J. Rogers, K.M. McIntyre, and S.I. Bangdiwala Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction JAMA 270 1993 1702 1707
34. M.R. Shah, V. Hasselblad, M. Gheorghiade, K.F. Adams, K. Swedberg, R.M. Califf, and C.M. O'Connor Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy Am J Cardiol 88 2001 987 993
35. C.P. Green, C.B. Porter, D.R. Bresnahan, and J.A. Spertus Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure J Am Coll Cardiol 35 2000 1245 1255
36. J. Spertus, E. Peterson, M.W. Conard, P.A. Heidenreich, H.M. Krumholz, and P. Jones Monitoring clinical changes in patients with heart failure: a comparison of methods Am Heart J 150 2005 707 715
37. M.A. Quiñones, B.H. Greenberg, H.A. Kopelen, C. Koilipillai, M.C. Limacher, and D.M. Shindler Echocardiographic predictors of clinical outcomes in patients with left ventricular dysfunction enrolled in the SOLVD Registry and Trials: significance of left ventricular hypertrophy J Am Coll Cardiol 35 2000 1237 1244
38. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
39. J.G.F. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger The effect of cardiac resynchronization on morbidity and mortality in heart failure N Eng J Med 352 2005 1539 1549
40. B.D. Lowes, E.M. Gilbert, W.T. Abraham, W.A. Minobe, P. Larrabee, and D. Ferguson Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N Engl J Med 346 2002 1357 1365
41. A. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, and J. Kjekshus Effect of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) study JAMA 283 2000 1295 1302
42. M. Packer, A.J. Coats, M.B. Fowler, A. Katus, H. Krum, and P. Mohacsi Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
43. S.A. Hall, C.G. Cigarroa, L. Marcoux, R.C. Risser, P.A. Grayburn, and E.J. Eichhorn Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1995 1154 1161
44. D. Bello, D.J. Shah, G.M. Farah, S. Di Luzio, M. Parker, and M.R. Johnson Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 2003 1945 1953
45. F. Waagstein, O. Stromblad, B. Andersson, M. Bohm, M. Darius, and W. Delius Increased ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double blind, placebo controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy Eur J Heart Fail 5 2003 679 691
46. R.J. Ivanhoe, M.R. Costanzo, W.T. Abraham, B. Rayburn on Behalf of the PEERLESS Investigators Ventricular restraint improves outcomes in HF patients with CRT J Cardiac Fail 17 2011 S41 S42